back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-02 16:03 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+15,000 vol |
15,000 | |
| Filed 2025-10-02 15:58 Tx date 2019-03-15 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-08-27 17:32 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-6,900 vol |
767 | |
| Filed 2025-08-27 17:31 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-574 vol |
61 | |
| Filed 2025-02-26 19:19 Tx date 2025-02-25 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+160,000 vol |
765,000 | |
| Filed 2025-01-27 17:44 Tx date 2025-01-24 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-8,889 vol |
635 | |
| Filed 2025-01-27 17:42 Tx date 2025-01-24 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-107,333 vol |
7,667 | |
| Filed 2025-01-08 16:57 Tx date 2025-01-08 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc. (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$26,875
+125,000 vol $0.215 each |
1,791,704 | |
| Filed 2025-01-08 16:56 Tx date 2025-01-08 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-125,000 vol |
605,000 | |
| Filed 2024-06-05 10:30 Tx date 2024-05-04 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc. (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-83,333 vol |
0 | |
| Filed 2024-02-26 13:06 Tx date 2024-02-23 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+160,000 vol |
730,000 | |
| Filed 2024-01-16 10:49 Tx date 2024-01-15 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc. (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$23,000
+100,000 vol $0.23 each |
1,666,704 | |
| Filed 2024-01-16 10:47 Tx date 2024-01-15 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
570,000 | |
| Filed 2023-06-20 13:47 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,200
+40,000 vol $6.03 each |
115,000 | |
| Filed 2023-02-28 08:53 Tx date 2023-02-27 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+160,000 vol |
670,000 | |
| Filed 2022-02-24 21:37 Tx date 2022-02-22 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+160,000 vol |
510,000 | |
| Filed 2022-01-13 17:11 Tx date 2022-01-13 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$423,500
+50,000 vol $8.47 each |
75,000 | |
| Filed 2022-01-13 16:59 Tx date 2022-01-13 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$423,500
+50,000 vol $8.47 each |
||
| Filed 2022-01-13 16:59 Tx date 2022-01-13 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$423,500
+50,000 vol $8.47 each |
75,000 | |
| Filed 2021-06-22 17:04 Tx date 2019-10-10 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
2,857,142 |